Current trends in theranostic applications of extracellular vesicles in cancer
Frontiers in Oncology · 03.06.2025 · 15
DOI: 10.3389/fonc.2025.1592006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 03.06.2025. Verfasst von Yazan Almasry und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, Alfaisal University, Riyadh, Saudi Arabia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 298 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Extracellular vesicles (EVs) play an integral role in cancer biology, influencing tumor progression, metastasis, and tumor microenvironment. Due to their distinctive molecular composition, including proteins, nucleic acids, and lipids, EVs present a promising candidate for cancer diagnostics and precision therapeutics.
Methods
This review was conducted by looking up recent studies obtained through PubMed, Scopus, and Web of Science databases using targeted keywords such as “Extracellular Vesicles,” “Cancer Therapy,” “Biomarkers,” “Exosomes,” “Tumor Microenvironment,” and “Precision Medicine.” From an initial 4,320 articles identified, 427 were screened after applying publication filters, resulting in the inclusion of 298 articles relevant to EV isolation, characterization, diagnostic sensitivity, specificity, and therapeutic efficacy.
Results
Biomarkers derived from EVs derived across various cancers showed high diagnostic performance. For example, four miRNA EVs showing sensitivity and specificity of 98% and 96% respectively was found in breast cancer. EV-RNA and surface antigen analyses for hepatocellular carcinoma with 93.8% sensitivity and 74.5% specificity. Additionally, EV biomarker cancers of the colorectal microRNA miR-23a and miR-301a had 89% sensitivity and >70% specificity. EVs in a therapeutic context were an effective drug delivery system for enhancing precision of chemotherapy and immunotherapy with reduced systemic toxicity.
Conclusion
The theranostics of EVs provide great capacity for early cancer diagnosis and personalized treatment based on their high diagnostic sensitivity and specificity. Future standardization protocols are essential to translate EV technologies into clinical oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
- Research Center, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia.
- Comparative Medicine Department, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
Zitieren
APA
Almasry, Y., Mustafa, F., Alfuwais, M., AlNachef, S., Mohamed, H., Gaber, N. S., Khan, M. I., Saadeldin, I. M., & Yaqinuddin, A. (2025). Current trends in theranostic applications of extracellular vesicles in cancer. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1592006
Vancouver
Almasry Y, Mustafa F, Alfuwais M, AlNachef S, Mohamed H, Gaber NS, et al. Current trends in theranostic applications of extracellular vesicles in cancer. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1592006
BibTeX
@article{Almasry2025,
author = {Almasry, Yazan and Mustafa, Fayrouz and Alfuwais, Mohammed and AlNachef, Sara and Mohamed, Hager and Gaber, Nusaibah S and Khan, Mohammed Imran and Saadeldin, Islam M and Yaqinuddin, Ahmed},
title = {Current trends in theranostic applications of extracellular vesicles in cancer},
journal = {Frontiers in Oncology},
year = {2025},
volume = {15},
doi = {10.3389/fonc.2025.1592006}
}
EUVIMED